Aubry Miller

Dr. Aubry Miller

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Nature
Verified
Journal Article
Open access
PDF file
DSDeniz Senyilmaz
Deniz Senyilmaz
SVSam Virtue
Sam Virtue
XXXiaojun Xu
Xiaojun Xu
CTChong Yew Tan
Chong Yew Tan
JGJulian L. Griffin
Julian L. Griffin
ATAurelio A. Teleman
Aurelio A. Teleman
Mitochondria have essential functions within cells, and their dysfunction is linked to various disorders; here, the fatty acid stearic acid (C18:0), which is a dietary component, and the transferrin receptor (TFR1) are shown to regulate mitochondrial function. In a study of the regulation of mitochondrial function, Aurelio Teleman and colleagues find that the fatty acid stearic acid (C18:0) and the protein transferrin receptor (TFR1) are both mitochondrial regulators. C18:0 acts by stearoylating TFR1, thereby inhibiting its activation of JNK signalling and promoting mitochondrial fusion and function. C18:0 is a dietary component and, intriguingly, animal cells respond to both increases and decreases in C18:0 levels. Dietary supplementation with C18:0 enhances mitochondrial fusion in Drosophila, counteracting the mitochondrial dysfunction caused by genetic defects such as the loss of the Parkinson's associated genes Pink and Parkin in models of the disease. Mitochondria are involved in a variety of cellular functions, including ATP production, amino acid and lipid biogenesis and breakdown, signalling and apoptosis1,2,3. Mitochondrial dysfunction has been linked to neurodegenerative diseases, cancer and ageing4. Although transcriptional mechanisms that regulate mitochondrial abundance are known5, comparatively little is known about how mitochondrial function is regulated. Here we identify the metabolite stearic acid (C18:0) and human transferrin receptor 1 (TFR1; also known as TFRC) as mitochondrial regulators. We elucidate a signalling pathway whereby C18:0 stearoylates TFR1, thereby inhibiting its activation of JNK signalling. This leads to reduced ubiquitination of mitofusin via HUWE1, thereby promoting mitochondrial fusion and function. We find that animal cells are poised to respond to both increases and decreases in C18:0 levels, with increased C18:0 dietary intake boosting mitochondrial fusion in vivo. Intriguingly, dietary C18:0 supplementation can counteract the mitochondrial dysfunction caused by genetic defects such as loss of the Parkinson’s disease genes Pink or Parkin in Drosophila. This work identifies the metabolite C18:0 as a signalling molecule regulating mitochondrial function in response to diet.

15 September 2022 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
UBUladzimir Barayeu
Uladzimir Barayeu
DSDanny Schilling
Danny Schilling
MEMohammad Eid
Mohammad Eid
TSThamara Nishida Xavier da Silva
Thamara Nishida Xavier da Silva
LSLisa Schlicker
Lisa Schlicker
TDTobias P. Dick
Tobias P. Dick
Ferroptosis is a type of cell death caused by radical-driven lipid peroxidation, leading to membrane damage and rupture. Here we show that enzymatically produced sulfane sulfur (S0) species, specifically hydropersulfides, scavenge endogenously generated free radicals and, thereby, suppress lipid peroxidation and ferroptosis. By providing sulfur for S0biosynthesis, cysteine can support ferroptosis resistance independently of the canonical GPX4 pathway. Our results further suggest that hydropersulfides terminate radical chain reactions through the formation and self-recombination of perthiyl radicals. The autocatalytic regeneration of hydropersulfides may explain why low micromolar concentrations of persulfides suffice to produce potent cytoprotective effects on a background of millimolar concentrations of glutathione. We propose that increased S0biosynthesis is an adaptive cellular response to radical-driven lipid peroxidation, potentially representing a primordial radical protection system.

1 December 2006 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AMAubry Miller
Aubry Miller
CHChambers C. Hughes
Chambers C. Hughes
JKJoshua J. Kennedy-Smith
Joshua J. Kennedy-Smith
SGStefan N. Gradl
Stefan N. Gradl
DTDirk Trauner
Dirk Trauner

14 February 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
Stefan PuschStefan Pusch
Stefan Pusch
LSLeonille Schweizer
Leonille Schweizer
ABAnn-Christin Beck
Ann-Christin Beck
JLJohanna-Marie Lehmler
Johanna-Marie Lehmler
SWSusanne Weissert
Susanne Weissert
ADAndreas von Deimling
Andreas von Deimling
IDH mutations frequently occur in diffuse gliomas and result in a neo-enzymatic activity that results in reduction of α-ketoglutarate to D-2-hydroxyglutarate. In gliomas, the frequency of IDH1 mutations in codon 132 increases in the order R132L-R132S-R132G-R132C-R132H with R132H constituting more than 90% of all IDH1 mutations.

9 April 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MGMagalie Géraldy
Magalie Géraldy
MMMichael Morgen
Michael Morgen
PSPeter Sehr
Peter Sehr
RSRaphael R. Steimbach
Raphael R. Steimbach
DMDavide Moi
Davide Moi
AMAubry Miller
Aubry Miller

24 June 1996 in Tetrahedron Letters
Verified
Journal Article
Closed access
SZShu-Hai Zhao
Shu-Hai Zhao
AMAubry Miller
Aubry Miller
JBJacob Berger
Jacob Berger
LFLee A. Flippin
Lee A. Flippin